Voting Rights Announcements | 3 January 2011 20:29


STRATEC Biomedical Systems AG: Release according to Article 26, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

STRATEC Biomedical Systems AG 

03.01.2011 20:29

Dissemination of a Voting Rights Announcement, transmitted by
DGAP - a company of EquityStory AG.
The issuer is solely responsible for the content of this announcement.
---------------------------------------------------------------------------


1st voting rights anouncement

FIL Limited, Hamilton, Bermuda, has notified us pursuant to section 21 (1)
WpHG on 23 December 2010, that on 20 December 2010 the share of voting
rights in STRATEC Biomedical Systems AG, Birkenfeld, Germany, ISIN:
DE0007289001 fell below the threshold of 3% and that the percentage of
voting rights on that day amounted to 2.99% (345,552 voting rights).

All voting rights in STRATEC Biomedical Systems AG were attributed to FIL
Limited pursuant to section 22 (1) sent. 1 no. 6 WpHG.


2nd voting rights anouncement

FIL Investment Management Limited, Hildenborough, Kent, UK, has notified us
pursuant to section 21 (1) WpHG on 23 December 2010, that on 20 December
2010 the share of voting rights in STRATEC Biomedical Systems AG,
Birkenfeld, Germany, ISIN: DE0007289001 fell below the threshold of 3% and
that the percentage of voting rights on that day amounted to 2.99% (345,552
votings rights).

All voting rights in STRATEC Biomedical Systems AG were attributed to FIL
Investment Management Limited pursuant to section 22 (1) sent. 1 no. 6 in
connection with sent. 2 WpHG.


3rd voting rights anouncement

FIL Investments International, Hildenborough, Kent, UK, has notified us
pursuant to section 21 (1) WpHG on 23 December  2010, that on 20 December
2010 the share of voting rights in STRATEC Biomedical Systems AG,
Birkenfeld, Germany, ISIN: DE0007289001 fell below the threshold of 3% and
that the percentage of voting rights on that day amounted to 2.99% (345,552
voting rights).

All voting rights in STRATEC Biomedical Systems AG were attributed to FIL
Investments International pursuant to section 22 (1) sent. 1 no. 6 WpHG.


4th voting rights anouncement

FIL Holdings Limited, Hildenborough, Kent, UK, has notified us pursuant to
section 21 (1) WpHG on 23 December 2010, that on 20 December 2010 the share
of voting rights in STRATEC Biomedical Systems AG, Birkenfeld, Germany,
ISIN: DE0007289001 fell below the threshold of 3% and that the percentage
of voting rights on that day amounted to 2.99% (345,552 votings rights).

All voting rights in STRATEC Biomedical Systems AG were attributed to FIL
Holdings Limited pursuant to section 22 (1) sent. 1 no. 6 in connection
with sent. 2 WpHG.


5th voting rights anouncement

Fidelity Funds SICAV, Luxembourg, Luxembourg, has notified us pursuant to
section 21 (1) WpHG on 23 December 2010, that on 20 December 2010 the share
of voting rights in STRATEC Biomedical Systems AG, Birkenfeld, Germany,
ISIN: DE0007289001 fell below the threshold of 3% and that the percentage
of voting rights on that day amounted to 2.99% (345,552 voting rights).



03.01.2011 DGAP's Distribution Services include Regulatory Announcements, 
Financial/Corporate News and Press Releases.
Media archive at www.dgap-medientreff.de and www.dgap.de

---------------------------------------------------------------------------
 
Language:     English
Company:      STRATEC Biomedical Systems AG
              Gewerbestraße 37
              75217 Birkenfeld
              Deutschland
Internet:     www.stratec-biomedical.de
 
End of Announcement                             DGAP News-Service
 
---------------------------------------------------------------------------